Global Women Healthcare Market Overview:
Women Healthcare is becoming an urgent priority across the globe. With the changing behaviour is bringing huge growth potential in future. As increasing number of women’s problems, basically gynecology is a basic branch of medical science that is concerned with women’s health. Along with within current market situation players are highly focusing specifically on women healthcare. Some of the key players profiled in the study are Pfizer (United States), Merck (United States), Eli Lilly and Company (United States), Becton Dickinson and Company (BD) (United States), Bayer (Germany), Amgen (United States), Allergan (Ireland), Agile Therapeutics Inc. (United States), Ferring Pharmaceuticals (United States) and Mylan N.V. (United States).
On the basis of geography, the market of Women Healthcare has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Drugs, the sub-segment i.e. Prolia will boost the Women Healthcare market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Women Health Devices, the sub-segment i.e. Surgical will boost the Women Healthcare market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Rising Occurrence of Chronic Health Conditions among Women
- High Demand for Contraceptives to Avoid Unplanned Pregnancies
- Increasing Number of Government Initiatives to Limit Population Growth
- High adoption of Prolia in women’s healthcare market, along with growing Population and Urbanization are major factors are responsible for the strong potential of the market across the globe.
- Emerging Markets across the Globe
- High Investment in Research and Development Initiatives
- Unwillingness to Use Contraceptives
Major Market Developments:
In Aug 2019, HSHS Medical group announced the acquisition of Vita Center for Women to expand its offering of primary and specialty care services. Vita is a high-quality provider of women’s health care in the Decatur region. HSHS is trying to make progress toward improving women’s health care in Macon County.
In Apr 2019, Kindbody announced the investment of nearly USD 22 million for reinventing women’s health care with the help of brick and mortar, mental health, nutrition, gynecological, and mobile clinics. Through this step, the company can capture the growing demand in the market.
The companies functioning in these industries are concentrating more on effective growth, improvement of operational efficiency and productivity, achieving high safety standards, and focus on maintaining sustainable development. The players are converging towards securing a leading position in this industry. They are endlessly observing for the opportunity to reinforce their competitive advantage. To meet great vendors share, and developing socially responsible business companies are identifying various strategic pillars such as mergers & acquisitions, new product launch, product enhancement, and others.
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Women Healthcare Products Manufacturers, Suppliers and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries
Major Objectives Focused through this Study
To define, describe, and forecast the Global Women Healthcare market on the basis of product [Pregnancy, Menopause and Female Organ] , application [Hospitals, Obstetrics & Gynecology Clinics, Diagnostic Laboratories and Ambulatory Surgical Centers], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Women Healthcare market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Women Healthcare industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Lupin (India), Blairex Laboratories (United States) and Apothecus Pharmaceutical (United States).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Women Healthcare market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.